A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of …

Artículos que citan A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of …

Título / Autor	Año
Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening RA Smith, D Manassaram‐Baptiste, D Brooks, M Doroshenk, S Fedewa, ... CA: a cancer journal for clinicians 65 (1), 30-54	2015
A biopsy-based 17-gene genomic prostate score predicts recurrence after radical prostatectomy and adverse surgical pathology in a racially diverse population of men with clinically low-and intermediate-risk prostate cancer J Cullen, IL Rosner, TC Brand, N Zhang, AC Tsiatis, J Moncur, A Ali, ... European urology 68 (1), 123-131	2015
The diagnosis and treatment of prostate cancer: a review MS Litwin, HJ Tan Jama 317 (24), 2532-2542	2017
Genomic predictors of outcome in prostate cancer PJ Boström, AS Bjartell, JWF Catto, SE Eggener, H Lilja, S Loeb, ... European urology 68 (6), 1033-1044	2015
Female leadership, performance, and governance in microfinance institutions RØ Strøm, B D’Espallier, R Mersland Journal of Banking & Finance 42, 60-75	2014
Active surveillance for prostate cancer: current evidence and contemporary state of practice JJ Tosoian, HB Carter, A Lepor, S Loeb Nature Reviews Urology 13 (4), 205	2016
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies B Rini, A Goddard, D Knezevic, T Maddala, M Zhou, H Aydin, S Campbell, ... The lancet oncology 16 (6), 676-685	2015
A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy EA Klein, K Yousefi, Z Haddad, V Choeurng, C Buerki, AJ Stephenson, ... European urology 67 (4), 778-786	2015
Tissue-based genomics augments post-prostatectomy risk stratification in a natural history cohort of intermediate-and high-risk men AE Ross, MH Johnson, K Yousefi, E Davicioni, GJ Netto, L Marchionni, ... European urology 69 (1), 157-165	2016
Decipher genomic classifier measured on prostate biopsy predicts metastasis risk EA Klein, Z Haddad, K Yousefi, LLC Lam, Q Wang, V Choeurng, ... Urology 90, 148-152	2016
Development and clinical validation of an in situ biopsy-based multimarker assay for risk stratification in prostate cancer P Blume-Jensen, DM Berman, DL Rimm, M Shipitsin, M Putzi, TP Nifong, ... Clinical cancer research 21 (11), 2591-2600	2015
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis SG Zhao, SL Chang, DE Spratt, N Erho, M Yu, HAD Ashab, M Alshalalfa, ... The lancet oncology 17 (11), 1612-1620	2016
Active surveillance for prostate cancer: a narrative review of clinical guidelines SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ... Nature Reviews Urology 13 (3), 151	2016
Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes SA Tomlins, M Alshalalfa, E Davicioni, N Erho, K Yousefi, S Zhao, ... European urology 68 (4), 555-567	2015
Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators L Wei, J Wang, E Lampert, S Schlanger, AD DePriest, Q Hu, EC Gomez, ... European urology 71 (2), 183-192	2017
Novel biomarker signature that may predict aggressive disease in African American men with prostate cancer K Yamoah, MH Johnson, V Choeurng, FA Faisal, K Yousefi, Z Haddad, ... Journal of Clinical Oncology 33 (25), 2789	2015
The Present and Future of Biomarkers in Prostate Cancer: Proteomics, Genomics, and Immunology Advancements: Supplementary Issue: Biomarkers and their Essential Role in the Development of Personalised Therapies (A) PO Gaudreau, J Stagg, D Soulières, F Saad Biomarkers in cancer 8, BIC. S31802	2016
Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer AE Ross, AV D'amico, SJ Freedland Prostate cancer and prostatic diseases 19 (1), 1	2016
Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells Q Zheng, L Banaszak, S Fracci, D Basali, SM Dunlap, SD Hursting, ... Endocrine-related cancer 20 (6), 797-808	2013
Immunohistochemistry and mass spectrometry for highly multiplexed cellular molecular imaging RM Levenson, AD Borowsky, M Angelo Laboratory Investigation 95 (4), 397	2015

1 - 20

Las fechas y los recuentos de citas son estimados y se determinan de forma automática mediante un programa informático.